Table 2.
SSc n = 43 (%) | SjS/SLE (n = 48) (%) | DM (n = 15) (%) | PBC (n = 15) (%) | p (SSc vs. SjS/SLE) | p (SSc vs. DM) | p (SSc vs. PBC) | p (SjS/SLE vs. DM) | p (SjS/SLE vs. PBC) | p (DM vs. PBC) | |
---|---|---|---|---|---|---|---|---|---|---|
Full antigen | 100 | 100 | 100 | 100 | NS | NS | NS | NS | NS | NS |
Ro52-1 | 11.6 | 41.7 | 20 | 6.7 | 0.001 | NS | NS | NS | 0.01 | NS |
Ro52-2 | 100 | 100 | 100 | 100 | NS | NS | NS | NS | NS | NS |
Ro52-3 | 0 | 0 | 0 | 0 | NS | NS | NS | NS | NS | NS |
Ro52-4 | 27.9 | 50.0 | 33.3 | 6.7 | 0.03 | NS | NS | NS | 0.002 | NS |
Ro52-5 | 41.9 | 58.3 | 40 | 40.0 | NS | NS | NS | NS | NS | NS |
SSc, systemic sclerosis; SjS, Sjögrens syndrome; SLE, systemic lupus erythematosus; PBC, primary biliary cholangitis. Significant p-values are indicated in bold.